Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Vectibix (panitumumab) Important Safety Information from Amgen as approved by the Irish Medicines Board

18 July 2012

Important Safety Information communication from Amgen on the association of panitumumab with life-threatening and fatal infectious complications of severe skin reactions including necrotising fasciitis.

Important Safety Information Vectibix (panitumumab)





Date Printed: 19 June 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971